John J. Boniface
Net Worth
Last updated:
What is John J. Boniface net worth?
The estimated net worth of Dr. John J. Boniface is at least $3,258,793 as of 11 Nov 2024. He owns shares worth $281,520 as insider, has earned $1,430,513 from insider trading and has received compensation worth at least $1,546,760 in Sera Prognostics, Inc..
What is the salary of John J. Boniface?
Dr. John J. Boniface salary is $386,690 per year as Chief Scientific Officer in Sera Prognostics, Inc..
How old is John J. Boniface?
Dr. John J. Boniface is 63 years old, born in 1962.
What stocks does John J. Boniface currently own?
As insider, Dr. John J. Boniface owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Sera Prognostics, Inc. (SERA) | Chief Scientific Officer | 125,120 | $2.25 | $281,520 |
What does Sera Prognostics, Inc. do?
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
John J. Boniface insider trading
Sera Prognostics, Inc.
Dr. John J. Boniface has made 35 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 4,727 units of SERA stock worth $34,602 on 11 Nov 2024.
The largest trade he's ever made was exercising 75,998 units of SERA stock on 11 Mar 2022. As of 11 Nov 2024 he still owns at least 125,120 units of SERA stock.
Sera Prognostics key executives
Sera Prognostics, Inc. executives and other stock owners filed with the SEC:
- Dr. Gregory C. Critchfield M.D., M.S. (72) Executive Chairman, Chief Executive Officer & Pres
- Dr. John J. Boniface (63) Chief Scientific Officer
- Ms. Nadia F. Altomare (55) Chief Commercial Officer